Convenia is a long-acting antibiotic injection used in dogs and cats to treat skin infections, wounds, and abscesses. It is manufactured by Zoetis, a global animal health company.
Convenia was first approved by the U.S. Food and Drug Administration (FDA) in 2012. It was quickly adopted by veterinarians as a convenient and effective treatment option for skin infections in dogs and cats.
However, in recent years, a number of lawsuits have been filed against Zoetis alleging that Convenia is associated with serious side effects, including:
- Anaphylaxis: A life-threatening allergic reaction
- Sepsis: A serious infection that can lead to organ failure
- Myoclonus: Involuntary muscle spasms
- Neurological disorders: Such as seizures, ataxia, and tremors
In 2023, a federal judge in California ruled that the plaintiffs in a class-action lawsuit against Zoetis could proceed with their claims. The judge found that there was sufficient evidence to support the plaintiffs’ allegations that Convenia was associated with serious side effects.
As a result of the lawsuit, Zoetis has agreed to pay $250 million to settle claims from pet owners who have experienced serious side effects from Convenia. The settlement is still subject to court approval.
The Convenia lawsuit is a reminder of the potential risks associated with any medication, even those that are considered to be safe and effective. It is important to talk to your veterinarian about the risks and benefits of any medication before giving it to your pet.
